Report: China Plans BioNTech Booster for Its Population
By Shannon Tiezzi
The report from Caixin comes as the efficacy of homegrown vaccines from Sinopharm and Sinovac continue to be questioned.
Fosun’s $700 Million Club Med Bid: Chinese Tourism’s Great Leap Forward?
China’s tourism industry is on its way, as a bid for Club Med attests.